OncologyEducation.com

oncologyeducation.com site map

Published: Sat Aug 12, 2000 Updated:Mon Sep 26, 2011

Home Created:0 Updated:2012-04-08 11:52:49

Networking Created:2011-04-27 20:27:00 Updated:2012-04-09 14:10:42
- Research Created:2012-03-05 09:35:45 Updated:2012-03-05 09:35:45
- - Clinical Trials Created:2011-06-08 21:44:00 Updated:2011-06-17 09:43:19
- - Grants Created:2011-04-29 12:39:00 Updated:2012-03-05 09:34:47
  - - Provincial Funding Organizatons Created:2011-04-29 12:42:00 Updated:2011-06-17 09:42:33
  - - International Funding Organizatons Created:2011-04-29 12:41:00 Updated:2011-06-17 09:42:05
  - - National Funding Organizatons Created:2011-04-29 12:41:00 Updated:2011-06-17 09:41:14
- - Cooperative Groups Created:2011-04-29 12:38:00 Updated:2012-03-05 09:33:23
- Cancer Centres and Societies Created:2011-04-29 12:33:44 Updated:2011-04-29 12:33:44
- - Cancer Societies and Associations Created:2011-04-29 12:44:00 Updated:2011-09-09 11:13:43
- - Cancer Centers Created:2011-04-29 12:43:50 Updated:2011-04-29 12:43:50
  - - International Created:2011-04-29 12:48:00 Updated:2011-06-17 10:03:24
  - - Canada Created:2011-04-29 12:47:00 Updated:2011-07-06 20:21:29
  - - United States Created:2011-04-29 12:47:00 Updated:2011-06-17 09:44:41
- - Other Links Created:2011-04-25 12:50:00 Updated:2011-09-20 14:32:26
- Oncology Groups Created:2011-04-29 12:33:22 Updated:2011-04-29 12:33:22
- - COMET Created:2011-04-29 12:52:00 Updated:2012-05-17 18:19:19
- Job Postings Created:2011-04-29 12:33:00 Updated:2012-03-27 12:17:53
- - New Brunswick Created:2012-03-01 11:16:01 Updated:2012-03-01 11:16:01
- - Prince Edward Island Created:2011-09-20 12:25:00 Updated:2011-12-09 18:05:41
- - British Columbia Created:2011-04-29 12:50:00 Updated:2012-02-03 08:45:49
- - Saskatchewan Created:2011-04-29 12:50:00 Updated:2012-02-03 08:50:20
- - Ontario Created:2011-04-29 12:49:00 Updated:2012-05-04 07:42:00
- - Alberta Created:2011-04-29 12:48:00 Updated:2012-03-27 11:22:56
- Graduate Programs Created:2011-04-29 12:26:00 Updated:2011-04-29 12:30:31
- - Education Created:2011-05-08 12:35:00 Updated:2012-03-05 10:24:13
- - Research Created:2011-04-29 12:43:00 Updated:2011-06-17 09:37:04

Information Created:2011-04-27 20:27:00 Updated:2012-05-09 12:14:50
- Teaching Cases Created:2011-06-08 20:36:00 Updated:2012-05-08 10:42:31
- GU Created:2011-04-29 14:02:00 Updated:2012-05-08 10:32:37
- - Multimedia Created:2011-11-28 14:44:00 Updated:2011-11-28 14:44:41
- - Guidelines Created:2011-10-07 18:41:00 Updated:2011-10-07 18:44:20
  - - Kidney Cancer Created:2011-10-19 19:26:00 Updated:2011-10-20 19:50:36
  - - Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma Created:2011-10-07 18:42:00 Updated:2011-10-07 18:43:26
- - Latest Oncology Updates Created:2011-04-29 19:31:00 Updated:2011-06-13 09:45:31
  - - Older Conference Updates Created:2011-09-15 10:29:00 Updated:2011-09-26 16:01:19
    - - May 2007 ASCO Created:2011-04-29 14:11:00 Updated:2011-09-14 18:28:33
    - - November 2007 KCA Created:2011-04-29 14:10:00 Updated:2011-09-14 18:25:49
    - - July 2008 ASCO Created:2011-04-29 14:09:00 Updated:2011-09-14 18:22:54
    - - April 2008 ASCO Created:2011-04-29 14:09:00 Updated:2011-09-14 18:23:45
    - - June 2009 ASCO Created:2011-04-29 14:08:00 Updated:2011-09-14 18:18:18
    - - August 2009 Journal Articles Created:2011-04-29 14:08:00 Updated:2011-09-14 18:17:33
    - - March 2009 ASCO Created:2011-04-29 14:08:00 Updated:2011-09-14 18:19:54
    - - December 2009 Created:2011-04-29 14:07:00 Updated:2011-09-14 18:15:58
    - - November 2009 Created:2011-04-29 14:07:00 Updated:2011-09-14 18:16:44
  - - July 2011 ACOG Created:2011-07-12 18:10:00 Updated:2012-01-28 09:21:01
  - - June 2011 ASCO Created:2011-06-21 21:19:00 Updated:2011-09-14 18:11:39
  - - May 2011 ASCO Created:2011-05-31 21:48:00 Updated:2012-01-28 09:31:38
  - - June 2010 ASCO Created:2011-04-29 14:07:00 Updated:2011-09-14 18:15:06
  - - July 2010 Created:2011-04-29 14:07:00 Updated:2011-09-14 18:14:17
  - - October 2010 ESMO Created:2011-04-29 14:06:00 Updated:2011-09-14 18:13:27
- - Key Journal Articles Created:2011-04-29 14:05:00 Updated:2011-10-13 13:31:52
  - - Bladder - Neoadjuvant Chemotherapy Created:2011-10-21 10:33:00 Updated:2011-10-21 10:34:39
    - - Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis Created:2011-10-13 14:14:28 Updated:2011-10-13 14:14:28
    - - Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer Created:2011-10-13 14:13:57 Updated:2011-10-13 14:13:57
    - - Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer Created:2011-10-13 14:12:17 Updated:2011-10-13 14:12:17
  - - Bladder - Adjuvant Chemotherapy Created:2011-10-21 10:32:00 Updated:2011-10-21 10:33:27
    - - The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: What we do not know and why Created:2011-10-13 14:15:17 Updated:2011-10-13 14:15:17
  - - Prostate - Other Articles Created:2011-10-13 14:55:00 Updated:2011-10-21 10:39:50
    - - Abiraterone acetate improves fatigue in prostate cancer patients Created:2011-11-07 20:54:31 Updated:0
    - - SELECT Study: Vitamin E and the Risk of Prostate Cancer Created:2011-10-19 11:45:47 Updated:0
    - - Prostate-Specific Antigen and Pain Surrogacy Analysis in Metastatic Hormone-Refractory Prostate Cancer - Article Review by Dr Lori Wood Created:2011-10-13 14:53:47 Updated:2011-10-13 14:53:47
  - - Prostate - Systemic Therapy Post Docetaxel in a Metastatic Setting Created:2011-10-13 14:51:00 Updated:2011-10-21 10:39:02
    - - Prostate Cancer: Evolution or Revolution? Created:2011-10-19 19:03:03 Updated:0
    - - Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomized open-label trial Read a review of this article by Dr. Lori Wood Created:2011-10-13 14:53:24 Updated:2011-10-13 14:53:24
    - - Abiraterone and Increased Survival in Metastatic Prostate Cancer Read a review of this article by Dr. Lori Wood Created:2011-10-13 14:52:54 Updated:2011-10-13 14:52:54
  - - Prostate - Secondary Hormonal Manipulation Created:2011-10-13 14:44:00 Updated:2011-10-21 10:38:40
    - - Antiandrogen Withdrawal Alone or in Combination with Ketoconazole in Androgen-Independent Prostate Cancer Patients: A Phase III Trial (CALGB 9583) Created:2011-10-13 14:50:00 Updated:2011-10-13 14:50:00
    - - Flutamide Versus Prednisone in Patients With Prostate Cancer Symptomatically Progressing After Androgen-Ablative Therapy: A Phase III Study of the European Organization for Research and Treatment of Cancer Genitourinary Group Created:2011-10-13 14:49:40 Updated:2011-10-13 14:49:40
  - - Prostate - Immunotherapy in Metastatic Disease Created:2011-10-13 14:39:00 Updated:2012-01-14 16:21:02
    - - Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer Created:2011-10-13 14:40:40 Updated:2011-10-13 14:40:40
  - - Prostate - Chemotherapy in Metastatic Disease Created:2011-10-13 14:33:00 Updated:2011-10-21 10:37:32
    - - Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study Created:2011-11-09 20:20:14 Updated:0
    - - Phase II Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer Created:2011-11-03 20:48:32 Updated:0
    - - Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points Created:2011-10-13 14:37:51 Updated:2011-10-13 14:37:51
    - - Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer Created:2011-10-13 14:37:25 Updated:2011-10-13 14:37:25
    - - Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer Created:2011-10-13 14:36:33 Updated:2011-10-13 14:36:33
    - - Double-Blinded Randomized Study of High-Dose Calcitriol Plus Docetaxel Compared with Placebo Plus Docetaxel in Androgen-Independent Prostate Cancer: A Report from the ASCENT Investigators Created:2011-10-13 14:35:57 Updated:2011-10-13 14:35:57
    - - Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapy Created:2011-10-13 14:35:40 Updated:2011-10-13 14:35:40
  - - Prostate - Bone Targeted Therapies Created:2011-10-13 14:18:00 Updated:2011-10-21 10:36:56
    - - Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: Results of a phase 3, randomised, placebo-controlled trial Created:2012-01-18 21:06:29 Updated:0
    - - Bone scan index: A quantitative treatment response biomarker for castration-resistant metastatic prostate cancer Created:2012-01-18 21:01:12 Updated:0
    - - Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma Created:2012-01-18 20:53:48 Updated:0
    - - Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Created:2012-01-18 20:45:19 Updated:0
    - - Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial Created:2011-11-28 19:36:09 Updated:0
    - - Should Bisphosphonates be Used Routinely in Patients with Prostate Cancer metastatic to Bone? Created:2011-10-13 14:32:21 Updated:2011-10-13 14:32:21
    - - A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients with Hormone-Refractory Metastatic Prostate Carcinoma Created:2011-10-13 14:31:43 Updated:2011-10-13 14:31:43
    - - Bisphosphonates in Prostate Cancer: Where Are We and Where Should We Go? Created:2011-10-13 14:31:19 Updated:2011-10-13 14:31:19
    - - Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate versus Mitoxantrone/Prednisone and Placebo in Patients with Hormone-Refractory Prostate Cancer and Pain Created:2011-10-13 14:30:44 Updated:2011-10-13 14:30:44
    - - A Double-Blind, Placebo-Controlled, Randomized Trial of Oral Sodium Clodronate for Metastatic Prostate Cancer (MRC PR05 Trial) Created:2011-10-13 14:25:57 Updated:2011-10-13 14:25:57
    - - Combined Analysis of Two Multicenter, Randomized, Placebo-Controlled Studies of Pamidronate Disodium for the Palliation of Bone Pain in Men with Metastatic Prostate Cancer Created:2011-10-13 14:25:23 Updated:2011-10-13 14:25:23
    - - Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer Created:2011-10-13 14:24:35 Updated:2011-10-13 14:24:35
    - - Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study Read a review of this article by Dr. Lori Wood Created:2011-10-13 14:24:18 Updated:2011-10-13 14:24:18
    - - Changes in PSA kinetics predict metastasis-free survival in men with PSA-recurrent prostate cancer treated with nonhormonal agents Created:2011-10-13 14:23:57 Updated:2011-10-13 14:23:57
    - - Prostate Cancer Biomarkers: Research Updates at AUA Annual Meeting Created:0 Updated:2011-10-13 14:22:55
  - - Renal Cell - Immunotherapy Created:2011-10-13 13:54:00 Updated:2011-10-21 10:31:01
    - - Interferon Gamma-1b Compared with Placebo in Metastatic Renal-Cell Carcinoma Created:2011-10-13 13:57:44 Updated:2011-10-13 13:57:44
    - - Interferon-α and survival in metastatic renal carcinoma: early results of a randomised controlled trial Created:2011-10-13 13:57:21 Updated:2011-10-13 13:57:21
    - - Systemic therapy for renal cell Created:2011-10-13 13:56:33 Updated:2011-10-13 13:56:33
    - - Medroxyprogesterone, Interferon alfa-2a, Interleukin 2, or Combination of Both Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis: Results of a Randomized Controlled Trial (The PERCY QUATTRO Trial) Created:2011-10-13 13:56:05 Updated:2011-10-13 13:56:05
  - - Renal Cell - Cytoreductive Nephrectomy Created:2011-10-13 13:46:00 Updated:2011-10-21 10:30:26
    - - Radical nephrectomy plus interferon-α-based immunotherapy compared with interferon-α alone in metastatic renal-cell carcinoma: a randomised trial Created:2011-10-13 13:53:48 Updated:2011-10-13 13:53:48
    - - Nephrectomy Followed by Interferon-α-2b Compared with Interferon-α-2b Alone for Metastatic Renal-Cell Cancer Created:2011-10-13 13:52:55 Updated:2011-10-13 13:52:55
  - - Renal Cell - Bisphosphonates Created:2011-10-13 13:41:00 Updated:2011-10-21 10:29:56
    - - Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma Created:2011-10-13 13:43:05 Updated:2011-10-13 13:43:05
  - - Renal Cell - Targeted Therapy First Line Created:2011-10-07 18:45:00 Updated:2011-10-21 10:29:33
    - - Sarcomatoid-variant Renal Cell Carcinoma: Treatment Outcome and Survival in Advanced Disease Created:2011-11-07 20:47:12 Updated:0
    - - Critical appraisal of pazopanib as treatment for patients with advanced metastatic renal cell carcinoma Created:2011-10-13 13:43:00 Updated:2011-10-13 14:03:52
    - - Targeted Therapy for Metastatic Renal Cell Carcinoma Created:2011-10-13 13:38:25 Updated:2011-10-13 13:38:25
    - - Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma Created:2011-10-13 13:38:02 Updated:2011-10-13 13:38:02
    - - Sunitinib versus Interferon-α in Metastatic Renal-Cell Carcinoma Created:2011-10-13 13:37:34 Updated:2011-10-13 13:37:34
    - - Temsirolimus, Interferon-α, or Both for Advanced Renal-Cell Carcinoma Created:2011-10-13 13:37:03 Updated:2011-10-13 13:37:03
    - - Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomized, double-blind phase III trial Created:2011-10-13 13:36:29 Updated:2011-10-13 13:36:29
    - - Quality of Life in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib or Interferon Alfa: Results From a Phase III Randomized Trial Created:2011-10-13 13:36:06 Updated:2011-10-13 13:36:06
    - - Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial Created:2011-10-13 13:35:44 Updated:2011-10-13 13:35:44
    - - Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma Created:2011-10-13 13:34:40 Updated:2011-10-13 13:34:40
    - - Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial Created:2011-10-13 13:34:20 Updated:2011-10-13 13:34:20
    - - Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial Created:2011-10-13 13:33:00 Updated:2011-10-13 13:33:53
  - - Germ Cell - PET Scan Imaging Created:2011-10-07 17:32:00 Updated:2011-10-21 10:27:52
    - - 18Fluorodeoxyglucose Positron Emission Tomography in the Prediction of Relapse in Patients with High-Risk, Clinical Stage I Nonseminomatous Germ Cell Tumors: Preliminary Report of MRC Trial TE22 - The NCRI Testis Tumour Clinical Study Group Created:2011-10-07 18:37:16 Updated:2011-10-07 18:37:16
    - - 2-18fluoro-deoxy-D-glucose Positron Emission Tomography Is a Reliable Predictor for Viable Tumor in Postchemotherapy Seminoma: An Update of the Prospective Multicentric SEMPET Trial *New* Created:2011-10-07 18:36:54 Updated:2011-10-07 18:36:54
  - - Germ Cell - Relapsed GCT Created:2011-10-07 17:30:00 Updated:2011-10-21 10:27:25
    - - Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma Created:2011-11-09 20:41:30 Updated:0
    - - High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumours Created:2011-10-07 18:36:10 Updated:2011-10-07 18:36:10
  - - Germ Cell - Post Chemotherapy Surgery Created:2011-10-07 17:28:00 Updated:2011-10-21 10:26:59
    - - Weighing Risks and Benefits of Postchemotherapy Retroperitoneal Lymph Node Dissection: Not So Easy (Editorial) Created:2011-10-07 17:35:34 Updated:2011-10-07 17:35:34
    - - Management of Disseminated Nonseminomatous Germ Cell Tumors With Risk-Based Chemotherapy Followed by Response-Guided Postchemotherapy Surgery Created:2011-10-07 17:35:00 Updated:2011-10-07 18:35:24
    - - Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients With Disseminated Nonseminomatous Germ Cell Tumors: Is a Postchemotherapy Retroperitoneal Lymph Node Dissection Needed After Complete Remission? Created:2011-10-07 17:24:00 Updated:2011-10-07 18:35:00
  - - Germ Cell - Metastatic Created:2011-10-07 17:27:00 Updated:2011-10-21 10:26:10
    - - International Germ Cell Consensus Classification: a prognostic factor- based staging system for metastatic germ cell cancers Created:2011-10-07 11:03:00 Updated:2011-10-07 18:34:27
  - - Germ Cell - Stage I NSGCT Created:2011-10-07 17:26:00 Updated:2011-10-21 10:24:23
    - - Randomized Trial of Two or Five Computed Tomography Scans in the Surveillance of Patients With Stage I Nonseminomatous Germ Cell Tumors of the Testis Created:2011-10-07 10:52:00 Updated:2011-10-07 17:36:36
    - - Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors Created:2011-10-07 10:51:00 Updated:2011-10-07 17:36:16
  - - Bladder - Chemotherapy in Metastatic Disease Created:2011-04-29 14:04:00 Updated:2011-10-21 10:32:32
    - - Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy Created:2011-10-13 14:16:14 Updated:2011-10-13 14:16:14
    - - Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study Created:2011-10-13 14:14:46 Updated:2011-10-13 14:14:46
    - - Prognostic Factors in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract Experiencing Treatment Failure With Platinum-Containing Regimens Created:2011-10-13 14:12:34 Updated:2011-10-13 14:12:34
  - - Renal Cell - Bone Targeted Therapy Created:2011-04-29 14:03:00 Updated:2011-10-21 10:31:32
    - - Prospective Evaluation of Analgesic Use and Risk of Renal Cell Cancer Created:2011-10-13 12:41:44 Updated:2011-10-13 12:41:44
- - Continuing Medical Education Activities Created:2011-04-29 14:02:00 Updated:2011-06-17 12:06:23
- GI Created:2011-04-29 13:58:00 Updated:2012-05-08 10:32:01
- - Multimedia Created:2011-11-28 14:33:00 Updated:2011-11-28 14:34:25
- - Key Journal Articles Created:2011-09-13 13:55:00 Updated:2011-10-15 08:41:23
  - - Gastric Adjuvant Created:2012-05-15 11:54:35 Updated:0
    - - Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: A FNCLCC and FFCD Multicenter Phase III Trial Created:2012-05-07 07:58:37 Updated:0
    - - Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Created:2012-01-12 20:06:52 Updated:0
    - - Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer Created:2011-10-06 22:08:30 Updated:2011-10-06 22:08:30
  - - Colorectal - Metastatic - Chemotherapy Created:2011-10-07 16:21:00 Updated:2011-10-15 17:07:07
    - - Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial Created:2012-05-14 19:25:38 Updated:0
    - - Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial Created:2012-04-18 10:38:00 Updated:2012-04-18 10:39:22
    - - Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer Created:2011-12-11 18:48:07 Updated:0
    - - Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment Created:2011-11-07 21:07:49 Updated:0
    - - Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial Created:2011-10-12 21:39:03 Updated:0
    - - Intermittent versus continuous oxaliplatin and fl uoropyrimidine combination chemotherapy for fi rst-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial Created:2011-10-12 21:32:22 Updated:0
    - - Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000–05): an open-label, randomised, phase 3 trial Created:2011-10-07 15:33:34 Updated:2011-10-07 15:33:34
  - - Colorectal Metastatic - EGFR Created:2011-10-07 16:20:00 Updated:2011-10-15 17:06:43
    - - Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study Created:2012-05-14 19:32:05 Updated:0
    - - First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study Created:2012-04-11 18:35:57 Updated:0
    - - Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study Created:2012-04-11 18:31:37 Updated:0
    - - Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer Created:2012-02-12 16:19:07 Updated:0
    - - Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer: Meta-analytical estimation and implications for therapeutic strategies. Created:2011-10-24 21:56:56 Updated:0
    - - The CRYSTAL Study: Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status Created:2011-10-17 12:27:29 Updated:2011-10-17 12:27:29
    - - Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial Created:2011-10-13 21:54:00 Updated:2011-10-24 22:00:19
    - - The OPUS Study: Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer Created:2011-10-07 16:06:00 Updated:2011-10-15 17:11:08
    - - Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer Created:2011-10-07 15:55:00 Updated:2011-10-07 15:56:23
    - - K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer Created:2011-10-07 15:44:58 Updated:2011-10-07 15:44:58
    - - The CRYSTAL Study: Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer Created:2011-10-07 15:44:00 Updated:2011-10-15 17:04:35
    - - The PRIME Study: Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer Created:2011-10-07 15:43:00 Updated:2011-10-15 17:03:40
  - - Pancreatic - Adjuvant Created:2011-10-06 22:18:00 Updated:2011-10-11 16:17:07
    - - Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial Created:2011-10-29 08:59:00 Updated:2011-10-29 09:13:55
    - - Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection Created:2011-10-17 12:40:00 Updated:2011-10-17 13:23:25
    - - A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer Created:2011-10-06 22:23:17 Updated:2011-10-06 22:23:17
    - - Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial Created:2011-10-06 22:22:35 Updated:2011-10-06 22:22:35
    - - Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma: A Randomized Controlled Trial Created:2011-10-06 22:21:43 Updated:2011-10-06 22:21:43
  - - Colon Adjuvant Created:2011-10-05 18:56:00 Updated:2011-10-15 08:01:09
    - - Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Created:2012-04-18 10:45:14 Updated:0
    - - MOSAIC Study: Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer Created:2011-10-17 09:57:00 Updated:2011-10-17 09:58:10
    - - XELOXA Study: Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer Created:2011-10-06 13:47:00 Updated:2011-10-15 16:43:45
    - - Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer: A Systematic Review and Meta-analysis Created:2011-10-05 18:53:14 Updated:2011-10-05 18:53:14
    - - Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses Created:2011-09-30 09:57:00 Updated:2011-09-30 09:58:28
  - - Rectal Adjuvant Created:2011-10-05 18:54:00 Updated:2011-10-15 08:01:44
    - - Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Created:2012-05-17 21:41:00 Updated:2012-05-17 21:41:30
    - - Chemotherapy with Preoperative Radiotherapy in Rectal Cancer Created:2011-10-17 09:48:02 Updated:0
    - - ACCORD Study: Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2 Created:2011-10-17 09:41:00 Updated:2011-11-28 15:38:58
    - - Is Preoperative Chemoradiotherapy Still the Treatment of Choice for Rectal Cancer? Created:2011-10-06 21:59:24 Updated:2011-10-06 21:59:24
    - - Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03 Created:2011-10-06 21:59:00 Updated:2011-10-06 21:59:00
  - - Pancreatic - Metastatic Created:2011-06-01 13:56:00 Updated:2011-10-14 08:12:59
    - - Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer Created:2011-10-07 15:20:12 Updated:2011-10-07 15:20:12
    - - Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303) Created:2011-10-06 22:25:53 Updated:2011-10-06 22:25:53
    - - Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205 Created:2011-10-06 22:24:59 Updated:2011-10-06 22:24:59
    - - Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study Created:2011-10-06 22:24:00 Updated:2012-03-23 14:44:59
    - - FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer Created:2011-10-06 22:24:00 Updated:2011-10-06 22:25:22
  - - Colorectal - Metastatic - anti VEGF/Double Biologics Created:2011-04-29 13:56:00 Updated:2011-12-09 18:04:17
    - - Randomized Phase II Trial of Cetuximab, Bevacizumab, and Irinotecan Compared With Cetuximab and Bevacizumab Alone in Irinotecan-Refractory Colorectal Cancer: The BOND-2 Study Created:2011-10-07 16:19:05 Updated:2011-10-07 16:19:05
    - - Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer Created:2011-10-07 16:18:51 Updated:2011-10-07 16:18:51
    - - A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer Created:2011-10-07 16:18:31 Updated:2011-10-07 16:18:31
    - - Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer Created:2011-10-07 16:17:19 Updated:2011-10-07 16:17:19
    - - Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer Created:2011-10-07 16:07:52 Updated:2011-10-07 16:07:52
    - - Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer Created:2011-10-07 16:07:24 Updated:2011-10-07 16:07:24
    - - Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200 Created:2011-10-07 16:07:06 Updated:2011-10-07 16:07:06
    - - Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study Created:2011-10-07 16:06:42 Updated:2011-10-07 16:06:42
    - - Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study Created:2011-10-07 16:06:00 Updated:2011-10-07 16:06:00
  - - Gastric Metastatic Created:2011-04-29 13:55:00 Updated:2012-05-15 11:57:15
    - - Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone Created:2012-04-11 18:41:35 Updated:0
    - - AVAGAST Study: Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer- A Randomized, Double-Blind, Placebo-Controlled Phase III Study Created:2011-11-04 12:31:00 Updated:2011-11-04 13:30:49
    - - TOGA Study: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Created:2011-10-17 12:31:22 Updated:0
    - - Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer Created:2011-10-06 22:06:53 Updated:2011-10-06 22:06:53
- - Latest Oncology Updates Created:2011-04-29 14:02:00 Updated:2011-09-21 13:11:04
  - - MAGIC 2012 Created:2012-03-18 21:54:00 Updated:2012-04-05 18:12:33
    - - Case #2: Liver Metastasis Resection Created:2012-04-28 22:08:02 Updated:2012-04-28 22:08:02
    - - Case #1: Rectal Cancer Created:2012-04-28 15:33:30 Updated:2012-04-28 15:33:30
    - - The Neoadjuvant Therapy of Gastroesophageal Junction Cancer – Preoperative Chemotherapy or Preoperative Chemo Radiation: A DEBATE Created:2012-04-28 11:26:34 Updated:2012-04-28 11:26:34
    - - Interventional Gastroenterologist’s Role in Gastrointestinal Cancer – Therapeutic Endoscopy Created:2012-03-18 22:32:00 Updated:2012-04-29 16:13:20
    - - Time to Initiation of Adjuvant treatment of Colon Cancer - Part 2 Created:2012-03-18 22:29:00 Updated:2012-04-28 22:14:39
    - - Time to Initiation of Adjuvant treatment of Colon Cancer - Part 1 Created:2012-03-18 22:29:00 Updated:2012-04-28 22:13:43
    - - Colorectal Cancer Screening - Part 1 Created:2012-03-18 22:21:00 Updated:2012-04-28 22:10:02
    - - Colorectal Cancer Screening - Part 2 Created:2012-03-18 22:21:00 Updated:2012-04-28 22:11:31
    - - Colorectal Cancer Screening - Part 3 Created:2012-03-18 22:21:00 Updated:2012-04-09 10:26:06
    - - Keynote Address - Libby Znaimer - A Patient Perspective Created:2012-03-18 22:10:00 Updated:2012-04-28 11:16:54
    - - Colorectal cancer and you, and me Created:2012-03-18 22:10:00 Updated:2012-04-28 10:43:11
    - - Update on Gastrointestinal Stromal Tumours - Part 1 Created:2012-03-18 22:07:00 Updated:2012-04-28 11:58:10
    - - Update on Gastrointestinal Stromal Tumours - Part 2 Created:2012-03-18 22:07:00 Updated:2012-04-28 15:26:35
    - - Update on Gastrointestinal Stromal Tumours - Part 3 Created:2012-03-18 22:07:00 Updated:2012-04-28 15:30:33
    - - Cytoreductive Surgery & Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Colorectal Cancer – The Toronto Program Created:2012-03-18 22:04:00 Updated:2012-04-28 11:56:34
  - - ASCO GI Symposium - January 2012 Created:2012-01-23 07:06:00 Updated:2012-03-18 18:43:29
    - - CTG AGITG CO.20 Created:2012-03-05 15:40:00 Updated:2012-03-05 20:14:51
    - - CORRECT Created:2012-03-05 15:36:00 Updated:2012-03-05 20:12:45
    - - NO16968 Trial Created:2012-03-05 15:33:00 Updated:2012-03-05 20:12:23
    - - GRANITE-1 Created:2012-03-05 15:23:00 Updated:2012-03-05 20:10:27
  - - EC5 - Colorectal Conference, October 2011 Created:2011-11-15 21:35:00 Updated:2011-11-21 16:50:51
  - - GI - October 2011 ECCO-ESMO Created:2011-09-28 19:16:00 Updated:2011-11-02 10:28:37
    - - ESMO 2011 - GI Cancer - KRAS mutants Created:2011-11-01 16:14:29 Updated:0
    - - ESMO 2011 - GI Cancer - VELOUR Study Created:2011-10-27 17:53:06 Updated:0
    - - ESMO 2011 - GI Cancer - RESPECT Study Created:2011-10-27 17:42:00 Updated:2011-10-27 17:42:36
    - - ESMO 2011 - GI Cancer - TAS 102 Study Created:2011-10-21 11:00:00 Updated:2011-10-27 13:37:50
  - - Older Conference Updates Created:2011-09-15 09:40:00 Updated:2011-09-26 16:04:02
    - - October 2007 ECCO Created:2011-04-29 14:01:00 Updated:2011-09-14 18:06:14
    - - May 2007 ASCO Created:2011-04-29 14:01:00 Updated:2011-09-14 18:08:46
    - - June 2007 ASCO Created:2011-04-29 14:01:00 Updated:2011-09-14 18:07:29
    - - April 2008 ASCO Created:2011-04-29 14:00:00 Updated:2011-12-08 17:58:31
    - - July 2008 ASCO Created:2011-04-29 14:00:00 Updated:2011-09-14 18:01:41
    - - June 2008 ASCO Created:2011-04-29 14:00:00 Updated:2011-09-14 18:02:29
    - - June 2009 ASCO Created:2011-04-29 13:59:00 Updated:2011-09-14 18:00:31
    - - October 2009 ECCO Created:2011-04-29 13:59:00 Updated:2011-09-14 17:59:37
  - - July 2011 ACOG Created:2011-07-12 18:24:00 Updated:2011-09-14 17:54:09
  - - June 2011 ASCO Created:2011-06-21 20:52:00 Updated:2011-09-14 17:55:10
  - - June 2010 ASCO Created:2011-04-29 13:58:00 Updated:2011-09-14 17:57:18
  - - November 2010 ESMO Created:2010-11-01 13:58:00 Updated:2011-09-14 17:56:09
- - Continuing Medical Education Activities Created:2011-04-29 13:57:00 Updated:2011-09-17 11:11:54
- Lung Created:2011-04-29 13:47:00 Updated:2012-05-08 10:31:23
- - Multimedia Created:2011-11-28 14:32:13 Updated:0
- - Key Journal Articles Created:2011-04-29 13:47:24 Updated:2011-04-29 13:47:24
  - - Metastatic Chemo Created:2011-04-29 13:47:00 Updated:2011-12-09 18:02:39
    - - Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study Created:2012-04-22 20:28:16 Updated:0
    - - Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial Created:2012-04-22 20:20:15 Updated:0
    - - Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial Created:2012-04-22 20:14:54 Updated:0
    - - Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): Created:2012-04-22 20:03:25 Updated:0
    - - Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer. Created:2012-04-22 19:58:35 Updated:0
    - - Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis Created:2011-10-19 19:15:57 Updated:0
    - - EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study Created:2011-10-19 19:15:00 Updated:2012-03-23 14:40:08
    - - A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC) Created:2011-10-07 17:01:00 Updated:2011-10-07 17:02:48
    - - Molecular Predictors of Response to Epidermal Growth Factor Receptor Antagonists in Non–Small-Cell Lung Cancer Created:2011-10-01 16:43:38 Updated:2011-10-01 16:43:38
    - - Phase II Clinical Trial of Chemotherapy-Naïve Patients 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer Created:2011-10-01 16:42:08 Updated:2011-10-01 16:42:08
    - - Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599 Created:2011-10-01 16:39:17 Updated:2011-10-01 16:39:17
    - - Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2 Created:2011-10-01 16:37:58 Updated:2011-10-01 16:37:58
    - - Sequential vs Concurrent Chemoradiation for Stage III Non–Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410 Created:2011-10-01 16:36:51 Updated:2011-10-01 16:36:51
    - - Concurrent chemo and radiation therapy improves long-term survival for inoperable stage III lung cancer Created:2011-10-01 16:35:39 Updated:2011-10-01 16:35:39
    - - Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial Created:2011-10-01 16:14:45 Updated:2011-10-01 16:14:45
  - - Early Stage Created:2011-04-29 13:46:00 Updated:2011-10-01 16:15:30
    - - A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer Created:2011-10-01 16:12:26 Updated:2011-10-01 16:12:26
    - - DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy Created:2011-10-01 16:10:29 Updated:2011-10-01 16:10:29
    - - Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Created:2011-10-01 16:04:47 Updated:2011-10-01 16:04:47
- - Latest Oncology Updates Created:2011-04-29 13:47:00 Updated:2011-05-29 14:10:05
  - - CLCCO Conference - January 2012 Created:2012-03-01 11:06:00 Updated:2012-03-18 18:47:53
    - - New Era of Cancer Care - Part 1 - EGFR in NSCLC - Dr Mok Created:2012-03-23 15:26:00 Updated:2012-03-26 19:58:13
    - - New Era of Cancer Care - Part 2 - Current Treatment Options- Dr Mok Created:2012-03-23 15:26:00 Updated:2012-03-26 20:05:47
    - - New Era of Cancer Care - Part 3 - ALK Mutation in NSCLC- Dr Mok Created:2012-03-23 15:25:00 Updated:2012-03-26 20:07:58
    - - New Era of Cancer Care - Part 4 - cMET in NSCLC- Dr Mok Created:2012-03-23 15:25:00 Updated:2012-03-26 20:09:02
    - - The Canadian Perspective on RTOG Studies Created:2012-03-18 18:29:00 Updated:2012-03-18 19:50:21
    - - What is the most relevant endpoint for Phase III NSCLC trials Created:2012-03-18 18:04:00 Updated:2012-03-22 15:39:24
    - - What is the most relevant endpoint for Phase III NSCLC trials Created:2012-03-18 18:04:00 Updated:2012-03-22 15:37:39
    - - Thoracic surgery in NSCLC Created:2012-03-14 20:06:00 Updated:2012-03-19 12:31:07
    - - What is the best EGFR TKI for NSCLC - Gefitinib Created:2012-03-14 20:05:00 Updated:2012-03-22 15:31:27
    - - What is the best EGFR TKI for NSCLC - Erlotinib Created:2012-03-14 20:05:00 Updated:2012-03-22 15:13:13
    - - What is the best EGFR TKI for NSCLC - Afatinib Created:2012-03-14 20:05:00 Updated:2012-03-22 15:11:56
    - - What is the best EGFR TKI for NSCLC - Dacomitinib Created:2012-03-14 20:05:00 Updated:2012-03-22 15:09:44
    - - RTOG in NSCLC Created:2012-03-14 20:03:00 Updated:2012-03-22 14:55:22
    - - Respiratory Session - Part 2 Created:2012-03-14 20:02:00 Updated:2012-03-22 14:53:16
    - - Respiratory Session - Part 1 Created:2012-03-14 20:02:00 Updated:2012-03-22 07:21:37
    - - Canadian Biomarker Consensus Created:2012-03-14 19:59:00 Updated:2012-03-22 14:56:12
    - - Lung Cancer Today and Tomorrow - Part 1 Created:2012-03-14 19:57:00 Updated:2012-03-22 15:06:46
    - - Canadian Contributions to Lung Cancer Clinical Trials Created:2012-03-14 19:54:00 Updated:2012-03-22 15:40:29
    - - Clinical Trials - Part 1 - Start Small Created:2012-03-01 16:22:00 Updated:2012-03-24 08:10:25
    - - Lung Cancer Today and Tomorrow - Part 2 Created:2012-03-01 16:22:00 Updated:2012-03-22 15:05:45
    - - Clinical Trials - Part 2 - Building a Network Created:2012-03-01 16:22:00 Updated:2012-03-22 15:53:12
    - - Clinical Trials - Part 3 - Have a Vision Created:2012-03-01 16:22:00 Updated:2012-03-22 15:51:21
    - - Clinical Trials - Part 4 - Be Helpful to Others Created:2012-03-01 16:22:00 Updated:2012-03-22 15:44:02
    - - Primary Endpoint in Lung Clinical Trials Created:2012-03-01 16:22:00 Updated:2012-03-22 15:41:26
    - - Lung Cancer Today and Tomorrow - Part 3 Created:2012-03-01 16:22:00 Updated:2012-03-22 15:04:33
    - - Lung Cancer Today and Tomorrow - Part 4 Created:2012-03-01 16:22:00 Updated:2012-03-22 15:00:12
  - - Lung - October 2011 ECCO-ESMO Created:2011-09-28 18:59:00 Updated:2011-10-27 13:51:37
    - - Lung Cancer Tweeter feed from ECCO-ESMO 2011 Created:2011-09-28 18:52:00 Updated:2011-10-03 10:27:16
    - - AVAPERL Lung cancer study Created:2011-09-28 18:34:28 Updated:2011-09-28 18:34:28
    - - Vantage 014 Lung cancer study Created:2011-09-28 18:32:49 Updated:0
  - - Older Conference Updates Created:2011-09-15 09:35:00 Updated:2011-09-26 16:02:49
    - - June 2007 ASCO Created:2011-04-29 13:50:00 Updated:2011-09-14 17:48:28
    - - September 2009 IASLC Created:0 Updated:2011-09-14 17:38:52
    - - June 2009 ASCO Created:0 Updated:2011-09-14 17:40:08
    - - December 2008 ESMO Created:0 Updated:2011-09-14 17:41:23
    - - September 2007 IASLC Created:0 Updated:2011-09-14 17:47:16
  - - July 2011 - World Lung Created:2011-06-27 21:08:00 Updated:2011-10-24 21:46:54
  - - June 2011 ASCO Created:2011-06-23 21:18:00 Updated:2011-09-14 17:50:03
  - - October 2010 ESMO Created:2010-10-28 21:12:00 Updated:2011-09-15 09:38:41
    - - October 2010 ESMO Lung Postcard Created:2010-10-01 23:22:00 Updated:2011-09-15 09:27:50
  - - June 2010 ASCO Created:0 Updated:2011-09-14 17:36:47
  - - May 2010 IPASS Created:0 Updated:2011-09-14 17:37:33
- - Continuing Medical Education Activities Created:2011-04-29 13:47:00 Updated:2011-07-27 21:07:39
- Breast Created:2011-04-29 13:12:00 Updated:2012-05-12 11:52:08
- - Multimedia Created:2011-11-28 14:30:00 Updated:2011-12-29 12:47:21
- - Latest Oncology Updates Created:2011-04-29 13:21:00 Updated:2011-04-30 16:34:28
  - - EBCC 2012 Updates Created:2012-04-09 09:17:00 Updated:2012-04-09 14:54:28
  - - December 2011 SABCS Created:2011-12-12 15:46:57 Updated:2011-12-12 15:46:57
    - - CLEOPATRA Study Created:2011-12-12 15:45:22 Updated:2011-12-12 15:45:22
    - - BOLERO-2 Updated Results Created:2011-12-12 15:44:11 Updated:0
  - - Breast - October 2011 ECCO-ESMO Created:2011-09-28 19:14:00 Updated:2011-10-27 13:50:20
    - - ESMO 2011 - Breast Cancer TDM-1 Created:2011-10-21 10:55:00 Updated:2011-10-21 10:55:40
    - - ESMO 2011 - Breast Cancer BOLERO-2 Created:2011-10-21 10:53:49 Updated:0
  - - Older Conference Updates Created:2011-09-15 08:48:00 Updated:2011-12-08 18:21:52
    - - December 2009 SABCS Created:2011-04-29 13:24:00 Updated:2011-12-06 11:22:15
      - SABCS 2009 - Breast Cancer Update Created:2011-12-06 11:21:17 Updated:0
    - - September 2009 ECCO Created:2011-04-29 13:24:00 Updated:2011-12-06 11:34:24
      - SOLTI - 0701 Created:2011-12-06 11:32:24 Updated:0
      - A Phase III, randomized, double-blind study of denosumab compared with zoledronic acid in the treatment of patients with bone metastases from breast cancer Created:2011-12-06 11:27:00 Updated:2011-12-06 11:30:14
    - - June 2009 ASCO Created:2011-04-29 13:24:00 Updated:2011-12-06 12:04:22
      - Efficacy of BSI-201, a PARP-Inhibitor in combination with Gemcitabine/Carboplatin in Triple Negative Breast Cancer: Randomized Phase II trial Created:2011-12-06 12:03:00 Updated:2011-12-06 12:04:54
      - Ribbon - 1 trial Created:2011-12-06 11:35:51 Updated:0
    - - December 2008 SABCS Created:2011-04-29 13:24:00 Updated:2011-09-14 17:27:00
    - - June 2008 ASCO Created:2011-04-29 13:24:00 Updated:2011-09-14 17:28:49
    - - January 2008 SABCS Created:2011-04-29 13:24:00 Updated:2011-09-14 17:30:09
    - - October 2007 ECCO Created:2011-04-29 13:24:00 Updated:2011-09-14 17:31:01
    - - June 2007 ASCO Created:2011-04-29 13:24:00 Updated:2011-09-14 17:31:58
  - - October 2010 ESMO Created:2011-05-30 13:13:00 Updated:2011-12-06 10:58:13
    - - ESMO 2010 - Best of Breast Cancer Created:2011-12-06 10:54:00 Updated:2011-12-06 10:59:57
  - - April 2010 EBCC Created:2011-04-29 13:24:00 Updated:2011-12-06 11:10:40
    - - EBCC 2010 - Breast Cancer Update Created:2011-12-06 11:09:00 Updated:2011-12-06 11:10:08
  - - June 2010 ASCO Created:2010-06-11 13:24:00 Updated:2011-12-06 11:07:45
    - - ASCO 2010 - Best of Breast Cancer Created:2011-12-06 11:04:11 Updated:0
- - Key Journal Articles Created:2011-04-29 13:21:00 Updated:2011-10-12 16:23:05
  - - Adjuvant Chemo Created:2011-04-29 13:31:00 Updated:2011-09-29 16:36:17
    - - Phase III Trial Evaluating Weekly Paclitaxel Versus Docetaxel in Combination With Capecitabine in Operable Breast Cancer Created:2012-04-24 18:48:00 Updated:2012-05-11 12:30:19
    - - Comparisons between different polychemotherapy regimens for early breast cancer: meta-analysis of long-term outcome amoung 100,000 women in 123 randomised trials. Created:2012-01-20 19:54:00 Updated:2012-05-11 13:18:59
    - - Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial Created:2012-01-20 19:54:00 Updated:2012-05-11 12:36:09
    - - Adjuvant capecitabine, docetaxel, cyclophosphamid, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial. Created:2012-01-20 19:54:00 Updated:2012-05-11 13:18:41
    - - Longer-Term Outcomes of Letrozole Versus Placebo After 5 Years of Tamoxifen in the NCIC CTG MA.17 Trial: Analyses Adjusting for Treatment Crossover Created:2011-11-09 21:00:00 Updated:2012-05-11 12:39:05
    - - Breast-Cancer Adjuvant Therapy with Zoledronic Acid Created:2011-11-03 20:30:00 Updated:2012-05-11 12:40:13
    - - Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up Created:2011-09-29 16:32:00 Updated:2012-05-11 13:29:11
    - - Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22 Created:2011-09-29 16:27:00 Updated:2012-05-11 13:28:21
    - - Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18 Created:2011-09-29 16:26:00 Updated:2012-05-11 13:27:44
    - - Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI Created:2011-09-29 16:19:00 Updated:2012-05-11 13:26:52
    - - A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer Created:2011-09-29 16:13:00 Updated:2012-05-11 13:18:07
    - - Adjuvant Chemotherapy in Older and Younger Women With Lymph Node–Positive Breast Cancer Created:2011-09-29 16:11:00 Updated:2012-05-11 13:25:27
    - - Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Created:2011-09-29 16:09:00 Updated:2012-05-11 13:25:08
    - - Selection of Adjuvant Chemotherapy for Treatment of Node-positive Breast Cancer Created:2011-09-29 16:04:00 Updated:2012-05-11 13:14:09
    - - Adjuvant Chemotherapy for Patients With Estrogen Receptor--Positive Breast Cancer Created:2011-09-29 15:57:00 Updated:2012-05-11 13:10:20
    - - Adjuvant Therapy for Breast Cancer in Older Women Created:2011-09-29 15:55:00 Updated:2012-05-11 13:05:43
    - - Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer Created:2011-09-29 15:51:00 Updated:2012-05-11 13:23:17
    - - HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy Created:2011-09-29 15:50:00 Updated:2012-05-11 13:23:01
    - - Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer Created:2011-09-29 15:48:00 Updated:2012-05-11 13:22:43
    - - Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial Created:2011-09-29 15:47:00 Updated:2012-05-11 13:22:27
    - - Meta-analysis of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists' Collaborative Group overview Created:2011-09-29 15:45:00 Updated:2012-05-11 12:56:12
    - - Current Concepts: Local Therapy and Survival in Breast Cancer Created:2011-09-29 15:44:00 Updated:2012-05-11 13:21:56
    - - Her2 and Response to Paclitaxel in Node Positive Breast Cancer Created:2011-09-28 14:07:00 Updated:2012-05-11 13:21:42
    - - Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Created:2011-09-28 14:06:00 Updated:2012-05-11 13:21:26
    - - Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 Created:2011-09-28 14:03:00 Updated:2012-05-11 13:20:42
    - - Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open label, phase III, randomised controlled trial Created:2011-09-28 14:00:00 Updated:2012-05-11 13:19:56
    - - Phase III Study of Doxorubicin/Cyclophosphamide With Concomitant Versus Sequential Docetaxel As Adjuvant Treatment in Patients With Human Epidermal Growth Factor Receptor 2–Normal, Node-Positive Breast Cancer: BCIRG-005 Trial Created:2011-09-27 14:38:00 Updated:2012-05-11 12:41:54
  - - Surgery Created:2011-04-29 13:31:00 Updated:2011-09-29 20:29:18
    - - Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute Created:2011-09-29 20:26:00 Updated:2012-05-16 11:49:20
    - - Reanalysis and Results after 12 Years of Follow-Up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer Created:2011-09-29 20:25:00 Updated:2012-05-16 11:48:08
    - - Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave- Roussy Breast Cancer Group Created:2011-09-29 20:24:00 Updated:2012-05-16 11:45:38
    - - Case 35-2005 — A 56-Year-Old Woman with Breast Cancer and Isolated Tumor Cells in a Sentinel Lymph Node Created:2011-09-29 20:22:00 Updated:2012-05-14 17:22:54
  - - Bisphosphonates Created:2011-04-29 13:31:00 Updated:2011-09-29 19:28:09
    - - Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases Created:2011-09-29 19:26:00 Updated:2012-05-11 14:12:21
    - - Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment Created:2011-09-29 19:25:00 Updated:2012-05-11 14:11:41
    - - Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial Created:2011-09-29 19:24:00 Updated:2012-05-11 14:10:51
    - - Randomized, Placebo-Controlled Trial of Clodronate in Patients With Primary Operable Breast Cancer Created:2011-09-29 19:23:00 Updated:2012-05-11 14:09:50
  - - DCIS Created:2011-04-29 13:31:00 Updated:2011-09-29 20:36:54
    - - Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial Created:2011-09-29 20:36:00 Updated:2012-05-16 11:57:59
    - - Medical Progress: Ductal Carcinoma in Situ of the Breast Created:2011-09-29 20:34:00 Updated:2012-05-16 11:53:22
    - - Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS *New* Created:2011-09-29 20:32:00 Updated:2012-05-16 11:52:19
  - - Endocrine Created:2011-04-29 13:31:00 Updated:2011-10-01 15:26:29
    - - Zoledronic Acid in the Treatment of Early-Stage Breast Cancer: Is There a Final Verdict? Created:2011-12-11 16:12:00 Updated:2012-05-16 12:09:29
    - - Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up Created:2011-11-03 20:20:00 Updated:2012-05-16 12:14:33
    - - Five Versus More Than Five Years of Tamoxifen for Lymph Node-Negative Breast Cancer: Updated Findings From the National Surgical Adjuvant Breast and Bowel Project B-14 Randomized Trial Created:2011-10-01 15:24:53 Updated:2011-10-01 15:24:53
    - - Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group Created:2011-10-01 15:21:43 Updated:2011-10-01 15:21:43
    - - Anastrozole Alone or in Combination with Tamoxifen Versus Tamoxifen Alone for Adjuvant Treatment of Postmenopausal Women with Early Breast Cancer: first results of the ATAC randomised trial Created:2011-10-01 15:19:37 Updated:2011-10-01 15:19:37
    - - Advances in Endocrine Treatments for Postmenopausal Women with Metastatic and Early Breast Cancer Created:2011-10-01 15:16:03 Updated:2011-10-01 15:16:03
    - - A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer Created:2011-10-01 15:11:29 Updated:2011-10-01 15:11:29
    - - HABITS (hormonal replacement therapy after breast cancer-is it safe?), a randomised comparison: trial stopped Created:2011-10-01 15:10:15 Updated:2011-10-01 15:10:15
    - - Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer Created:2011-10-01 15:10:00 Updated:2012-05-16 12:00:03
    - - A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer Created:2011-10-01 15:08:42 Updated:2011-10-01 15:08:42
    - - Effects of Chemotherapy and Hormonal Therapy for Early Breast Cancer on Recurrence and 15-year Survival: an overview of the randomised trials Created:2011-10-01 15:06:58 Updated:2011-10-01 15:06:58
    - - Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial Created:2011-10-01 15:02:34 Updated:2011-10-01 15:02:34
    - - Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 Created:2011-10-01 15:01:08 Updated:2011-10-01 15:01:08
    - - A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer Created:2011-10-01 14:58:42 Updated:2011-10-01 14:58:42
    - - Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes Created:2011-10-01 14:57:29 Updated:2011-10-01 14:57:29
    - - Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial Created:2011-10-01 14:55:06 Updated:2011-10-01 14:55:06
    - - Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98 Created:2011-10-01 14:52:00 Updated:2012-05-16 12:44:48
    - - Breast Cancer Adjuvant Endocrine Therapy Created:2011-10-01 14:50:00 Updated:2012-05-16 12:43:35
    - - Cancer Therapy Disparity: Unequal Access to Breast Cancer Therapeutics and Drug Funding in Canada Created:2011-10-01 14:47:00 Updated:2012-05-16 12:41:19
    - - Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial Created:2011-10-01 14:45:00 Updated:2012-05-16 12:39:51
    - - BIG 1-98: A randomized double-blind phase III study evaluating letrozole and tamoxifen given in sequence as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer Created:2011-10-01 14:42:00 Updated:2012-05-16 12:36:40
    - - Survival and safety post study treatment completion: an updated analysis of the Intergroup Exemestane Study (IES) - submitted on behalf of the IES Investigators Created:2011-10-01 14:40:00 Updated:2012-05-16 12:16:35
    - - Disease Related Outcome with Long Term Follow-up: An Updated Analysis of the Intergroup Exemestane Study (IES) Created:2011-10-01 14:37:00 Updated:2012-05-16 12:38:14
  - - Genetics Created:2011-04-29 13:31:00 Updated:2011-10-01 15:33:29
    - - Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer Created:2011-10-01 15:31:29 Updated:2011-10-01 15:31:29
    - - Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations Created:2011-10-01 15:29:54 Updated:2011-10-01 15:29:54
  - - Metastatic Chemo Created:2011-04-29 13:31:00 Updated:2011-09-27 14:30:55
    - - Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group. Created:2011-12-11 18:57:00 Updated:2012-03-23 14:22:49
    - - Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer Created:2011-12-11 18:57:00 Updated:2012-05-11 12:16:34
    - - Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases Created:2011-12-11 16:00:00 Updated:2012-05-11 12:18:10
    - - Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results Created:2011-09-27 14:29:00 Updated:2012-05-11 12:27:01
    - - Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193) Created:2011-09-27 14:27:00 Updated:2012-05-11 12:26:15
    - - A systematic review of taxane-containing regimens for metastatic breast cancer Created:2011-09-27 14:26:00 Updated:2012-05-11 12:24:35
    - - Extending Survival with Chemotherapy in Metastatic Breast Cancer Created:2011-09-27 14:23:00 Updated:2012-05-11 12:22:20
    - - Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer Created:2011-09-27 14:23:00 Updated:2012-05-11 11:47:20
    - - First-line Treatment Options for Patients with HER-2 Negative Metastatic Breast Cancer: The Impact of Modern Adjuvant Chemotherapy Created:2011-09-27 14:20:00 Updated:2012-05-11 12:19:24
  - - Neoadjuvant Created:2011-04-29 13:31:00 Updated:2011-09-29 19:19:21
    - - Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial Created:2011-12-11 16:06:00 Updated:2012-05-11 13:31:52
    - - Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group Created:2011-10-12 20:55:00 Updated:2012-05-11 13:54:45
    - - Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Updat Created:2011-09-29 19:18:00 Updated:2012-05-11 13:53:24
    - - Effect of preoperative chemotherapy on the outcome of women with operable breast cancer Created:2011-09-29 19:13:00 Updated:2012-05-11 14:08:36
    - - Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study Created:2011-09-29 19:12:00 Updated:2012-05-11 14:07:55
    - - Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902 Created:2011-09-29 19:11:00 Updated:2012-05-11 14:05:38
    - - Neoadjuvant Chemotherapy in Breast Cancer: Significantly Enhanced Response With Docetaxel Created:2011-09-29 19:09:00 Updated:2012-05-11 14:04:28
    - - The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27 Created:2011-09-29 19:06:00 Updated:2012-05-11 14:03:52
    - - Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis Created:2011-09-29 19:05:00 Updated:2012-05-11 14:03:10
    - - Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution? Created:2011-09-29 19:03:00 Updated:2012-05-11 14:01:29
    - - Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer Created:2011-09-29 18:59:00 Updated:2012-05-11 14:00:38
    - - Neoadjuvant Treatment of Postmenopausal Breast Cancer With Anastrozole, Tamoxifen, or Both in Combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) Multicenter Double-Blind Randomized Trial Created:2011-09-29 18:55:00 Updated:2012-05-11 13:59:43
    - - Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks Created:2011-09-29 18:52:00 Updated:2012-05-11 13:59:06
    - - Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27 Created:2011-09-29 18:48:00 Updated:2012-05-11 13:52:45
    - - Neoadjuvant endocrine therapy in breast cancer Created:2011-09-29 18:47:00 Updated:2012-05-11 13:56:40
    - - Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer Created:2011-09-29 18:46:00 Updated:2012-05-11 13:49:39
    - - Neoadjuvant trastuzumab in locally advanced breast cancer (NOAH): Antitumour and safety analysis Created:2011-09-29 18:44:00 Updated:2012-05-11 13:47:59
    - - Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 Created:2011-09-29 18:43:00 Updated:2012-05-11 13:56:06
    - - The addition of zoledronic acid to neoadjuvant chemotherapy may influence pathological response – exploratory evidence for direct anti-tumor activity in breast cancer Created:2011-09-29 18:42:00 Updated:2012-05-11 13:55:37
    - - Neoadjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer: primary efficacy analysis of the NOAH trial Created:2011-09-29 18:40:00 Updated:2012-05-11 13:55:18
    - - Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902 Created:2011-09-29 18:37:00 Updated:2012-05-11 13:42:57
    - - New results from the use of bisphosphonates in cancer patients Created:2011-09-29 18:34:00 Updated:2012-05-11 13:40:50
    - - A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer Created:2011-09-29 16:39:00 Updated:2012-05-11 13:35:54
  - - Pregnancy Created:2011-04-29 13:31:00 Updated:2011-09-27 14:17:03
    - - Management of Breast Cancer During Pregnancy Using a Standardized Protocol Created:2011-09-27 14:15:00 Updated:2012-05-11 11:42:24
    - - Effect of Pregnancy on Overall Survival After the Diagnosis of Early-Stage Breast Cancer Created:2011-09-27 14:15:00 Updated:2012-05-11 11:43:17
  - - Prevention Created:2011-04-29 13:31:00 Updated:2011-10-12 16:25:17
    - - Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer Created:2012-01-12 20:15:00 Updated:2012-05-11 11:18:47
    - - Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study Created:2011-09-26 16:50:00 Updated:2012-05-11 11:23:35
    - - Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study Created:2011-09-26 16:42:00 Updated:2012-05-11 11:24:51
  - - Screening Created:2011-04-29 13:31:00 Updated:2011-09-27 14:01:33
    - - The Evolving Role of MRI in the Detection and Evaluation of Breast Cancer Created:2011-09-27 13:54:00 Updated:2012-05-11 11:36:12
    - - Mammographic Screening for Breast Cancer Created:2011-09-27 13:53:00 Updated:2012-05-11 11:38:21
    - - MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer Created:2011-09-27 13:51:00 Updated:2012-05-11 11:27:47
  - - Follow Up Created:2011-04-29 13:31:00 Updated:2011-10-01 15:41:22
    - - Potential Pitfalls of Crossover and Thoughts on Iniparib in Triple-Negative Breast Cancer Created:2011-11-09 21:37:13 Updated:0
    - - 2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology Created:2011-10-01 15:40:26 Updated:2011-10-01 15:40:26
    - - Follow-up care of patients treated for breast cancer: a structured review Created:2011-10-01 15:38:48 Updated:2011-10-01 15:38:48
    - - Management of Hot Flashes in Patients Who Have Breast Cancer With Venlafaxine and Clonidine: A Randomized, Double-Blind, Placebo-Controlled Trial Created:2011-10-01 15:36:43 Updated:2011-10-01 15:36:43
    - - Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics Created:2011-10-01 15:35:26 Updated:2011-10-01 15:35:26
  - - Targeted Agents Created:2011-04-29 13:31:00 Updated:2011-09-29 20:12:37
    - - Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2 Created:2011-09-29 20:10:00 Updated:2012-05-11 14:27:38
    - - Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer Created:2011-09-29 20:09:00 Updated:2012-05-11 14:26:35
    - - Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer Created:2011-09-29 20:07:21 Updated:2011-09-29 20:07:21
    - - Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer Created:2011-09-29 20:05:00 Updated:2012-05-11 14:24:55
    - - Herceptin and the Heart -- A Molecular Modifier of Cardiac Failure Created:2011-09-29 20:03:00 Updated:2012-05-11 14:22:49
    - - Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer Created:2011-09-29 20:00:00 Updated:2012-05-11 14:22:03
    - - Management of HER2-Positive Breast Cancer Created:2011-09-29 19:58:00 Updated:2012-05-11 14:21:25
    - - Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer Created:2011-09-29 19:57:00 Updated:2012-05-11 14:20:13
    - - 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial Created:2011-09-29 19:55:00 Updated:2012-05-11 14:19:23
    - - Bevacizumab for Advanced Breast Cancer Created:2011-09-29 19:53:00 Updated:2012-05-11 14:18:43
    - - Cardiac Management during Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group Created:2011-09-29 19:50:00 Updated:2012-05-11 14:16:57
    - - Treatment of Metastatic ErbB2-positive Breast Cancer: Options After Progression On Trastuzumab Created:2011-09-29 19:31:00 Updated:2012-05-11 14:16:11
- - Continuing Medical Education Activities Created:2011-02-11 13:22:00 Updated:2011-06-17 10:16:44
- Other Tumor Sites Created:2011-04-29 13:12:00 Updated:2012-05-08 10:36:05
- - Latest Oncology Updates Created:2012-04-09 15:36:02 Updated:0
  - - 2012 Canadian Melanoma Conference Created:2012-03-14 19:48:00 Updated:2012-04-09 15:30:28
- - Key Journal Articles Created:2012-03-23 14:52:02 Updated:2012-03-23 14:52:02
  - - A Phase 3 Trial of Bevacizumab in Ovarian Cancer Created:2012-03-23 14:49:09 Updated:0
- - Multimedia Created:2011-11-28 14:59:44 Updated:0
- - Continuing Medical Education Activities Created:2011-04-29 14:18:00 Updated:2011-06-17 12:18:01
- Supportive Care Created:2011-04-29 13:12:00 Updated:2012-05-09 12:16:28
- - Guidelines Created:2012-03-04 16:19:00 Updated:2012-03-04 16:23:56
  - - Antithrombotic Therapy Guidelines 2012: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Created:2012-03-04 16:22:00 Updated:2012-03-16 15:21:25
    - - Primary and Secondary Prevention of Cardiovascular Disease Created:2012-03-07 16:05:00 Updated:2012-03-16 15:34:29
    - - Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Created:2012-03-07 16:04:00 Updated:2012-03-16 15:32:37
    - - Antithrombotic and Thrombolytic Therapy for Valvular Disease Created:2012-03-07 16:01:00 Updated:2012-03-16 15:32:06
    - - Treatment and Prevention of Heparin-Induced Thrombocytopenia Created:2012-03-07 15:58:00 Updated:2012-03-16 15:31:30
    - - Antithrombotic Therapy for VTE Disease Created:2012-03-07 15:46:00 Updated:2012-03-16 15:30:38
    - - Diagnosis of DVT Created:2012-03-07 15:43:00 Updated:2012-03-16 15:30:06
    - - Perioperative Management of Antithrombotic Therapy Created:2012-03-07 15:41:00 Updated:2012-03-16 15:29:20
    - - Prevention of VTE in Nonsurgical Patients Created:2012-03-07 15:29:00 Updated:2012-03-16 15:27:04
    - - Approach to Outcome Measurement in the Prevention of Thrombosis in Surgical and Medical Patients Created:2012-03-07 15:27:00 Updated:2012-03-16 15:26:45
    - - Evidence-Based Management of Anticoagulant Therapy Created:2012-03-07 15:25:00 Updated:2012-03-16 15:25:39
    - - New Antithrombotic Drugs Created:2012-03-07 15:21:00 Updated:2012-03-16 15:25:07
    - - Antiplatelet Drugs Created:2012-03-07 15:19:00 Updated:2012-03-16 15:24:38
    - - Oral Anticoagulant Therapy Created:2012-03-07 15:17:00 Updated:2012-03-16 15:24:13
    - - Parenteral Anticoagulants Created:2012-03-07 15:15:00 Updated:2012-03-16 15:21:09
    - - Patient Values and Preferences in Decision Making for Antithrombotic Therapy: A Systematic Review Created:2012-03-07 15:13:00 Updated:2012-03-16 15:23:45
    - - Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines Created:2012-03-07 15:11:00 Updated:2012-03-16 15:23:12
- - Key Journal Articles Created:2011-12-06 12:10:00 Updated:2011-12-06 12:10:17
  - - Addition of iron to erythropoiesis-stimulating agents in cancer patients: A meta-analysis of randomized trials Created:2011-11-28 19:49:00 Updated:2011-11-28 19:49:48
  - - Cancer and pregnancy: A comprehensive review Created:2011-11-28 19:42:00 Updated:2011-11-28 19:44:34
  - - Preventing Infections in Cancer Patients Created:2011-11-28 19:40:03 Updated:0
- - ACOG July 2011 Created:2011-07-08 10:06:00 Updated:2012-03-05 12:12:39
- - Hot Spot Newsletter Created:2011-04-29 14:19:00 Updated:2012-04-20 10:10:43
- - Patient Care Created:2011-04-29 14:19:00 Updated:2011-06-17 12:18:49
- Head & Neck Created:2011-04-29 13:12:00 Updated:2012-05-08 10:33:47
- - Multimedia Created:2011-11-28 14:46:21 Updated:0
- - Latest Oncology Updates Created:2011-06-20 21:10:00 Updated:2011-06-20 21:12:12
  - - June 2011 ASCO Created:2011-06-20 21:21:00 Updated:2011-09-14 18:29:45
- - Key Journal Articles Created:2011-04-29 14:12:00 Updated:2011-10-13 15:09:23
  - - Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial Created:2012-05-17 21:26:03 Updated:0
  - - Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: Final results of a randomized, double-blind, placebo-controlled, phase 3 study Created:2012-05-17 21:18:05 Updated:0
  - - Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial Created:2012-05-17 21:12:39 Updated:0
  - - Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer Created:2012-05-17 21:02:23 Updated:0
  - - Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer Created:2012-05-17 20:48:09 Updated:0
  - - Podcast: ESMO 2011 Interview with Dr Camilla Hoff on the influence of smoking in patients with squamous cell carcinoma of the head and neck Created:2011-12-22 20:35:49 Updated:0
  - - Early Trial Supports Bevacizumab in Head and Neck Cancer Created:2011-12-22 20:33:55 Updated:0
  - - Thyroid cancer patients’ involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory study Created:2011-12-22 20:30:24 Updated:0
  - - Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial Created:2011-12-22 20:28:13 Updated:0
  - - The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease Created:2011-12-22 20:25:23 Updated:0
  - - Clinical significance of micrometastases in lymph nodes from laryngeal squamous cell carcinoma Created:2011-12-22 20:22:19 Updated:0
  - - Exploring novel therapeutic strategies for cetuximab in head and neck squamous cell carcinoma Created:2011-11-07 21:31:59 Updated:0
  - - New Guidelines for Reirradiation of Head and Neck Cancer Created:2011-11-07 21:24:26 Updated:0
  - - Podcast: ESMO 2011 Interview with Professor Jan Vermorken analyzing the results of the phase III SPECTRUM trial Created:2011-11-07 21:20:39 Updated:0
  - - HPV and Head and Neck Cancer Created:2011-10-19 20:50:08 Updated:0
  - - A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy Created:2011-10-19 20:41:00 Updated:2011-10-19 20:42:11
  - - Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis Created:2011-10-19 20:39:00 Updated:2011-10-19 20:43:30
  - - Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients Created:2011-10-19 20:35:00 Updated:2011-10-19 20:43:51
  - - Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer Created:2011-10-19 20:29:00 Updated:2011-10-19 20:29:55
  - - Radiotherapy plus Cetuximab for Squamous- Cell Carcinoma of the Head and Neck Created:2011-10-19 19:55:00 Updated:2011-10-19 19:56:12
  - - Increase in stroke risk in patients with head and neck cancer: a retrospective cohort study Created:2011-10-19 19:19:21 Updated:0
  - - Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer Article Review by Dr Snow Created:2011-10-13 09:32:07 Updated:2011-10-13 09:32:07
  - - Does PEG Use Cause Dysphagia in Head and Neck Cancer Patients? Created:2011-10-13 09:30:07 Updated:2011-10-13 09:30:07
  - - Distinct patterns of stomatitis with concurrent cetuximab and radiotherapy for head and neck squamous cell carcinoma Created:2011-10-13 09:27:41 Updated:2011-10-13 09:27:41
  - - Population-Based Study of Competing Mortality in Head and Neck Cancer Created:2011-10-13 09:27:16 Updated:2011-10-13 09:27:16
  - - Circulating Tumor Cell Assay Shows Potential for Predicting Prognosis in Head and Neck Carcinoma Created:2011-10-13 09:26:39 Updated:2011-10-13 09:26:39
  - - Anti-EGFR–targeting agents in recurrent or metastatic head and neck carcinoma: A meta-analysis Created:2011-10-13 09:26:16 Updated:2011-10-13 09:26:16
  - - Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer Created:2011-10-13 09:25:53 Updated:2011-10-13 09:25:53
- Hematology Created:2011-04-29 13:12:00 Updated:2012-05-08 10:34:21
- - Multimedia Created:2011-11-28 14:48:11 Updated:0
- - Continuing Medical Education Activities Created:2011-04-29 14:14:15 Updated:2011-04-29 14:14:15
  - - International Speaker Series: Leukemia Created:2011-04-29 14:17:00 Updated:2011-06-17 12:10:50
  - - International Speaker Series: Lymphoma Created:2011-04-29 14:17:00 Updated:2011-06-17 12:12:06
  - - International Speaker Series: Hematology Conference Created:2010-12-15 14:16:00 Updated:2011-06-15 21:01:51
- - Latest Oncology Updates Created:2011-04-29 14:13:25 Updated:0
  - - January 2009 ASH Created:2011-04-29 14:15:00 Updated:2011-09-14 18:36:11
  - - July 2010 ASCO & EHA Created:2011-04-29 14:14:00 Updated:2011-09-14 18:34:04
- Palliative Care Created:2011-04-29 13:12:00 Updated:2012-05-08 10:43:41
- - Multimedia Created:2011-06-13 10:27:00 Updated:2011-11-21 09:52:06
  - - Lecture 1 - Pain Management for the Medical and Hematological Oncologist Created:2011-12-29 12:34:30 Updated:0

Conferences Created:2011-04-29 11:59:00 Updated:2012-05-12 11:52:35
- ASCO 2012 Created:2012-05-12 11:49:00 Updated:2012-05-17 15:13:03
- - GI Cancer Updates - ASCO 2012 Created:2012-05-12 11:49:24 Updated:2012-05-12 11:49:24
- - Lung Cancer Updates - ASCO 2012 Created:2012-05-12 11:43:18 Updated:2012-05-12 11:43:18
- - Hematology Cancer Updates - ASCO 2012 Created:2012-05-12 11:42:40 Updated:2012-05-12 11:42:40
- - Head and Neck Cancer Updates - ASCO 2012 Created:2012-05-12 11:42:04 Updated:2012-05-12 11:42:04
- - GU Cancer Updates - ASCO 2012 Created:2012-05-12 11:41:13 Updated:2012-05-12 11:41:13
- - Breast Cancer Updates - ASCO 2012 Created:2012-05-12 11:38:00 Updated:2012-05-12 11:40:38
- Canadian Achievements in Cancer Research Created:2012-04-30 13:52:00 Updated:2012-05-11 09:59:26
- - Canadian Contributions to Cancer Clinical Trials - Panel Discussion Created:2012-05-01 18:54:00 Updated:2012-05-09 17:17:03
  - - One Mutation - Different Tumors Created:2012-05-01 18:54:00 Updated:2012-05-17 11:57:24
  - - Antracycline & Breast Cancer Created:2012-05-01 18:54:00 Updated:2012-05-09 17:04:53
  - - Mutations & Targeted Agents Created:2012-05-01 18:54:00 Updated:2012-05-09 17:06:23
  - - What is it about Canada that has allowed us to make such a contribution to clinical trials? Created:2012-05-01 18:54:00 Updated:2012-05-09 17:07:46
  - - Advice for Young Trainees Created:2012-05-01 18:54:00 Updated:2012-05-09 17:09:44
  - - Industrial Clinical Trials in Canada Created:2012-05-01 18:54:00 Updated:2012-05-09 17:11:01
  - - The Future of Clinical Trials in Canada Created:2012-05-01 18:54:00 Updated:2012-05-09 17:12:14
  - - Cost of Clinical Trials in Canada Created:2012-05-01 18:54:00 Updated:2012-05-09 17:13:43
- - Canadian Contributions to Prostate Cancer Clinical Trials Created:2012-05-01 18:52:53 Updated:2012-05-01 18:52:53
- - Canadian Contributions to Lung Cancer Clinical Trials Created:2012-05-01 18:51:59 Updated:2012-05-01 18:51:59
- - Canadian Contributions to Breast Cancer Clinical Trials Created:2012-05-01 18:51:06 Updated:2012-05-01 18:51:06
- - Canadian Contributions to Colorectal Cancer Clinical Trials Created:2012-04-30 13:53:00 Updated:2012-05-01 18:44:51
- Best of Oncology 2012 Created:2012-03-11 11:45:00 Updated:2012-03-30 09:36:18
- Past Conferences Created:2011-04-29 19:34:00 Updated:2011-11-30 22:45:45
- - Best of Oncology 2011 Created:2012-01-03 08:15:00 Updated:2012-03-18 18:41:56
- - ACTOC - October 2011 Created:2011-12-12 07:15:00 Updated:2012-03-18 18:39:30
  - - ACTOC Dr Xu Created:2011-12-12 07:14:05 Updated:2011-12-12 07:14:05
  - - ACTOC Dr Buduhan Created:2011-12-12 07:09:00 Updated:2011-12-12 07:10:37
  - - ACTOC Dr Videtic Created:2011-12-12 07:07:00 Updated:2011-12-12 07:08:15
  - - ACTOC 2011 Dr Mulroy Created:2011-12-12 07:05:45 Updated:2011-12-12 07:05:45
  - - ACTOC 2011 Dr Camidge Created:2011-12-12 06:54:22 Updated:0
- - ECCO-ESMO 2011 Created:2011-09-28 19:00:00 Updated:2011-11-30 22:50:30
- - ASCO 2011 Created:2011-06-21 21:40:00 Updated:2011-11-30 22:48:27
- - ACOG 2011 Created:2011-06-20 21:32:00 Updated:2011-11-30 22:47:47
- - ACOG 2010 Created:2010-08-23 19:34:00 Updated:2011-06-17 12:23:51
- - MOBS Conference 2010 Created:2010-07-22 19:34:00 Updated:2011-06-17 12:22:59
- - ACOG 2009 Created:2009-07-22 19:35:00 Updated:2011-06-17 12:24:23
- Oncology Conferences Created:2011-04-29 14:21:00 Updated:2012-02-01 20:00:27
- Events Calendar Created:2011-04-29 14:21:00 Updated:2011-08-04 12:06:40
- CME Events Created:2011-02-10 14:21:00 Updated:2011-10-25 22:26:32

Residents Created:2011-04-29 12:00:00 Updated:2012-04-09 14:11:09
- MOBS 2012 Created:2012-03-20 09:35:00 Updated:2012-05-17 14:17:06
- NOYCIA Awards Created:2012-03-20 09:22:00 Updated:2012-03-20 09:23:10
- Resident Links Created:2011-04-29 19:11:00 Updated:2011-09-16 13:17:40
- - Colleges and Other Organizations Created:2011-04-29 19:13:00 Updated:2011-06-13 14:10:05
  - - National Organizations Created:2011-04-29 19:17:00 Updated:2011-06-17 12:29:32
  - - Provincial Colleges Created:2011-04-29 19:17:00 Updated:2011-06-17 12:29:56
- - Canadian Residents Organizations Created:2011-04-29 19:13:00 Updated:2011-08-31 21:17:58
- - Oncology Residents Groups Created:2011-04-29 19:13:00 Updated:2011-06-17 12:31:35
- - Examinations and Licensing Created:2011-04-29 19:11:00 Updated:2011-06-17 12:28:32
- Fellowships Created:2011-04-29 19:10:00 Updated:2011-08-31 21:15:28
- - Canada Created:2011-05-22 10:31:00 Updated:2011-05-22 10:32:23
  - - Institution Based Created:2011-05-22 10:39:00 Updated:2012-04-12 08:22:33
  - - National Created:2011-05-22 10:33:00 Updated:2011-08-18 19:29:44
- - International Created:2011-05-22 10:28:00 Updated:2011-06-17 12:27:32
- - United States Created:2011-05-22 10:20:00 Updated:2011-06-17 12:27:07
- Canadian Medical Oncology Training Programs Created:2011-04-29 12:32:00 Updated:2011-09-16 12:13:12

In The Clinic Created:2011-04-29 12:01:00 Updated:2012-04-09 14:12:01
- Clinical Trials Created:2011-10-12 15:55:00 Updated:2012-04-09 13:55:04
- Decision Aids Created:2011-04-29 19:21:00 Updated:2011-06-17 12:33:12
- - Staging Tools Created:2011-04-29 19:36:00 Updated:2011-11-30 18:06:04
- Drug Information Created:2011-04-29 19:21:00 Updated:2012-05-08 13:59:41
- Treatment Summaries / Practice Guidelines Created:2011-04-29 19:20:00 Updated:2012-03-04 16:17:35

Multimedia Created:2011-04-29 12:01:00 Updated:2012-04-09 14:11:29
- Melanoma Created:2011-04-29 19:41:00 Updated:2012-03-07 16:50:07
- - Video Created:2011-10-05 18:43:00 Updated:2012-03-16 15:14:30
  - - SpotlightOnMelanoma ASCO 2011 Created:2011-07-14 21:10:00 Updated:2012-05-08 10:17:22
  - - SpotlightOnMelanoma ASCO 2010 Created:2011-05-31 09:38:00 Updated:2012-03-03 14:38:41
- Hematology Multimedia Created:2011-04-29 19:41:00 Updated:2012-02-24 12:19:31
- - Video Created:2011-10-05 18:45:00 Updated:2011-11-28 15:21:35
  - - Hematology Conference Created:2011-05-31 09:47:00 Updated:2012-03-03 14:53:05
  - - Leukemia Created:2011-05-31 09:45:00 Updated:2012-03-03 14:53:36
  - - Lymphoma Created:2011-05-31 09:42:00 Updated:2012-03-03 14:54:42
- Head & Neck Cancer Multimedia Created:2011-04-29 19:40:00 Updated:2012-03-07 16:49:12
- - Presentations Created:2011-04-29 19:29:00 Updated:2011-10-05 18:37:32
  - - Head and Neck Cancer (HNC): Train the trainer session Created:2011-10-03 21:30:00 Updated:2012-03-03 14:31:34
- Other Tumor Sites/General Topics Multimedia Created:2011-04-29 19:40:00 Updated:2012-03-07 16:49:37
- - Video Created:2011-10-05 18:46:00 Updated:2011-10-29 09:44:29
  - - Palliative Care Multimedia Created:2011-11-28 14:57:43 Updated:2011-11-28 14:57:43
  - - MOBS 2010 Created:2011-05-31 08:48:00 Updated:2012-03-02 20:48:24
  - - AnemiaFacultyProgramVerma.flv Created:2011-05-29 14:27:00 Updated:2011-11-28 15:26:47
- - Slide Kits & Presentations Created:2011-04-29 19:25:00 Updated:2012-05-11 14:26:57
  - - Bisphosphonates Created:2011-04-29 19:26:00 Updated:2011-06-17 12:17:25
  - - General Created:2011-04-29 19:25:00 Updated:2011-06-17 12:17:03
- Breast Cancer Multimedia Created:2011-04-29 19:39:00 Updated:2012-02-27 19:41:38
- - Video Created:2011-10-03 20:22:00 Updated:2012-05-04 07:17:01
  - - Have We Optimized Endocrine Therapy in Advanced Breast Cancer? Created:2012-05-08 10:06:00 Updated:2012-05-08 18:36:57
    - - Endocrine Therapy in Advanced Breast Cancer - State of the Art Created:2012-05-08 10:06:00 Updated:2012-05-08 17:56:42
    - - Endocrine Therapy in Advanced Breast Cancer - First Line Therapy Created:2012-05-08 10:06:00 Updated:2012-05-08 18:03:13
    - - Endocrine Therapy in Advanced Breast Cancer - Second Line Therapy Created:2012-05-08 10:06:00 Updated:2012-05-08 18:06:53
    - - Endocrine Therapy in Advanced Breast Cancer - Fulvestrant & NEWEST trial Created:2012-05-08 10:06:00 Updated:2012-05-08 18:09:26
    - - Endocrine Therapy in Advanced Breast Cancer - Fulvestrant in CONFIRM & FIRST trials Created:2012-05-08 10:06:00 Updated:2012-05-08 18:14:48
    - - Endocrine Therapy in Advanced Breast Cancer - Fulvestrant in FACT & SWOG trials Created:2012-05-08 10:06:00 Updated:2012-05-08 18:17:07
    - - Endocrine & Growth Factor Therapy in Advanced Breast Cancer Created:2012-05-08 10:06:00 Updated:2012-05-08 18:19:55
  - - Older Videos Created:2012-02-24 11:02:00 Updated:2012-05-04 07:18:26
    - - Breast Cancer 101 - Videos Created:2011-05-30 15:21:00 Updated:2012-02-24 11:19:30
      - AdjuvantEndocrineTreatment.flv Created:2011-05-29 14:27:00 Updated:2012-04-16 10:57:33
      - AdvancesInAdjuvantTherapy.flv Created:2011-05-29 14:27:00 Updated:2012-04-16 10:57:49
      - HER2Positive.flv Created:2011-05-29 14:27:00 Updated:2012-04-16 10:57:18
      - MetastaticBreastCancer.flv Created:2011-05-29 14:27:00 Updated:2012-02-24 11:04:40
      - MetastaticTargetedTherapy.flv Created:2011-05-29 14:27:00 Updated:2012-04-16 10:56:59
    - - LRCC - Breast Oncology Rounds - Nov 6, 2009 Created:2011-05-30 15:11:00 Updated:2011-06-10 15:53:43
    - - Targeted Therapy Update and Conclusion - SABCS 2009 Created:2011-05-30 14:45:00 Updated:2012-02-23 21:52:23
    - - SABCS 2008 Update Created:2011-05-29 14:27:00 Updated:2012-02-24 11:04:00
    - - BestofBreastASCO2009.flv Created:2011-05-29 14:27:00 Updated:2012-04-16 10:48:12
    - - Breast Cancer 101 - Breast Cancer Review Created:2011-05-29 14:27:00 Updated:2012-02-23 22:02:32
    - - Key Endocrine/Chemotherapy Update - SABCS 2009 Created:2011-05-29 14:27:00 Updated:2012-02-23 21:49:44
    - - Prevention/Lifestyle Factors and Biology - SABCS 2009 Created:2011-05-29 14:27:00 Updated:2012-02-23 21:13:48
  - - 2010 Videos Created:2012-02-24 10:56:00 Updated:2012-05-04 07:15:10
    - - Dialogues in Practice - Summary and Conclusion Created:2011-05-30 14:30:00 Updated:2012-02-23 21:12:17
    - - SABCS 2010 Update - Video Highlights - Conclusion Created:2011-05-30 12:59:00 Updated:2012-02-23 21:08:47
    - - SABCS 2010 Update - Video Highlights - Targeted Therapy Created:2011-05-30 12:57:00 Updated:2012-02-23 21:07:28
    - - SABCS 2010 Update - Video Highlights - Adjuvant Chemotherapy Created:2011-05-30 12:54:00 Updated:2012-02-23 21:08:12
    - - SABCS 2010 Update - Video Highlights - Adjuvant Bisphosphonates Created:2011-05-30 12:51:00 Updated:2012-02-23 21:06:21
    - - SABCS 2010 Update - Video Highlights - Hormone Receptor Positive Created:2011-05-30 12:49:00 Updated:2012-02-23 21:05:58
    - - SABCS 2010 Update - Video Highlights - Introduction Created:2011-05-30 12:46:00 Updated:2012-02-23 21:05:29
    - - Metastatic Breast Cancer - SABCS CORE 2010 Created:2011-05-30 12:37:00 Updated:2012-02-24 10:54:03
    - - Neoadjuvant Therapy Update - SABCS CORE 2010 Created:2011-05-30 12:32:00 Updated:2012-02-24 10:48:49
    - - Women in Cancer - SABCS CORE 2010 Created:2011-05-30 12:28:00 Updated:2012-02-24 10:48:00
    - - Future of Breast Cancer - SABCS CORE 2010 Created:2011-05-30 11:53:00 Updated:2012-02-24 09:36:11
    - - Introduction - SABCS CORE 2010 Created:2011-05-30 11:39:00 Updated:2012-02-23 22:00:31
    - - Current Landscape and Novel Chemotherapy Options - Best of Breast Cancer - ESMO 2010 Video Highlights Created:2011-05-29 14:27:00 Updated:2012-02-24 10:55:52
    - - Dialogues in Practice - Breast Cancer Treatment - Video Created:2011-05-29 14:27:00 Updated:2012-02-24 11:00:39
  - - Breast Cancer End Points Video - July 2011 Created:2011-09-23 09:25:00 Updated:2012-02-24 10:58:13
  - - Her-2 Positive - Best of Breast - ASCO 2011 Created:2011-07-21 23:47:00 Updated:2012-02-23 20:54:15
  - - New Approaches - Best of Breast - ASCO 2011 Created:2011-07-21 23:47:00 Updated:2012-02-23 20:54:53
  - - Triple Negative - Best of Breast - ASCO 2011 Created:2011-07-21 23:20:00 Updated:2012-02-23 20:51:33
  - - DrChiaBreastCancerQA_Jan2011.flv Created:2011-05-29 14:27:00 Updated:2012-02-23 20:58:30
  - - DrChiaBreastCancer_Jan2011.flv Created:2011-05-29 14:27:00 Updated:2012-02-23 20:58:02
- - Slide Decks Created:2011-04-29 19:32:00 Updated:2012-02-24 11:26:02
  - - Clinical Dilemma: Which Adjuvant Chemotherapy is Just Right? Created:2011-10-03 21:11:00 Updated:2012-02-27 07:07:51
  - - ‘Arimidex’, Tamoxifen, Alone or in Combination (ATAC) trial: Completed Treatment Analysis Created:2011-10-03 21:09:00 Updated:2012-02-27 07:14:26
  - - Breast Cancer & You Created:2011-10-03 20:37:00 Updated:2012-02-27 07:13:13
  - - Current Landscape and Future Directions of Docetaxel in Breast Cancer Created:2011-10-03 20:34:00 Updated:2012-02-27 07:11:16
  - - Chemotherapy Adjuvant Treatment (ChAT) for Breast Cancer in Young Women Created:2011-10-03 20:32:00 Updated:2012-02-27 07:10:04
  - - Breast Cancer Patient Issues in Family Practice: An Interactive Session Created:2011-10-03 20:26:00 Updated:2012-02-27 07:08:57
- Lung Cancer Multimedia Created:2011-04-29 19:39:00 Updated:2012-02-24 12:17:37
- - Video Created:2011-10-03 21:25:00 Updated:2012-05-15 13:09:45
  - - EGFR Inhibitors - Best of Lung - ASCO 2011 Created:2011-07-21 23:36:00 Updated:2012-02-27 07:55:51
  - - Maintenance Therapy - Best of Lung - ASCO 2011 Created:2011-07-21 23:21:00 Updated:2012-02-27 07:52:35
  - - Novel Drugs and Therapies - Best of Lung - ASCO 2011 Created:2011-07-21 23:21:00 Updated:2012-02-27 07:57:08
  - - Anti-Angiogenesis in First Line - Best of Lung - ESMO 2010 Created:2011-05-29 14:27:00 Updated:2012-02-27 07:58:32
  - - Update of EGFR Therapy - Best of Lung - ESMO 2010 Created:2011-05-29 14:27:00 Updated:2012-02-27 07:59:25
  - - Maintenance Therapy - Best of Lung - ESMO 2010 Created:2011-05-29 14:27:00 Updated:2012-02-27 08:00:17
- - Presentations Created:2011-04-29 19:31:00 Updated:2011-10-05 18:32:18
  - - Tarceva (BR.21 Schema) Created:2011-10-03 21:24:00 Updated:2012-02-27 19:49:50
- GU Cancer Multimedia Created:2011-04-29 19:39:00 Updated:2012-02-24 12:18:15
- - Video Created:2011-10-03 21:37:00 Updated:2011-11-01 16:45:47
  - - 4_Prognostic Factors.flv Created:2011-07-22 09:39:00 Updated:2012-03-03 14:24:42
  - - 1_Advances in Second-line Treatment.flv Created:2011-07-22 09:38:00 Updated:2012-03-03 14:22:43
  - - 2_Combination Therapy.flv Created:2011-07-22 09:38:00 Updated:2012-03-03 14:23:18
  - - 3_Adjuvant Therapy for Localized Disease.flv Created:2011-07-22 09:38:00 Updated:2012-03-03 14:23:56
  - - HengGUASCO2011/HengGUASCO2011_Dosing.flv Created:2011-05-29 14:27:00 Updated:2012-03-03 14:25:17
  - - HengGUASCO2011/HengGUASCO2011_NewDrugs.flv Created:2011-05-29 14:27:00 Updated:2012-03-03 14:25:53
  - - HengGUASCO2011/HengGUASCO2011_PredictingFuture.flv Created:2011-05-29 14:27:00 Updated:2012-03-03 14:26:57
  - - HengGUASCO2011/HengGUASCO2011_Progression.flv Created:2011-05-29 14:27:00 Updated:2012-03-03 14:26:25
- - Presentations Created:2011-04-29 19:31:00 Updated:2011-11-01 16:47:24
  - - Contemporary Managment Strategies for Patients with Hormone-Refractory Prostate Cancer (HRPC) Created:2011-10-03 22:02:00 Updated:2012-03-03 14:02:17
- GI Cancer Multimedia Created:2011-04-29 14:01:00 Updated:2012-05-15 13:06:36
- - Presentations Created:2012-03-03 13:35:00 Updated:2012-05-15 12:51:54
  - - Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial Created:2012-01-03 11:25:00 Updated:2012-03-03 13:48:25
  - - Defining the Role of EGFR Monoclonal Antibody Therapy in Metastatic Colorectal Cancer Created:2012-01-03 11:24:00 Updated:2012-03-03 14:06:14
- - Videos Created:2012-03-03 13:35:00 Updated:2012-05-15 13:03:56

Log In Created:2011-05-09 16:39:00 Updated:2012-05-08 15:26:22
- Log Out Created:2012-03-15 16:12:00 Updated:2012-04-18 15:32:55
- Change Your Password Created:2011-06-15 22:02:00 Updated:2012-03-15 16:01:12
- Update Your Profile Created:2011-05-18 20:32:00 Updated:2012-03-15 16:02:02
- Your Profile Created:2011-05-18 13:26:00 Updated:2012-03-15 16:16:19

Contact Us Created:2011-05-31 11:37:00 Updated:2011-06-17 12:38:00
- Site Map Created:2000-08-12 18:52:00 Updated:2011-09-26 16:06:32

rss-feed Created:2011-06-16 12:19:00 Updated:2012-01-14 16:36:10

Twitter Created:2000-06-16 12:21:00 Updated:2012-01-14 16:43:40

linkedin Created:2000-07-19 21:42:00 Updated:2012-01-14 16:44:05

facebook Created:2000-07-19 21:43:00 Updated:2012-01-14 16:45:17

Site Search

Sign-up for Our E-Newsletter

Help Us Grow!

Learn more about contributing to our website.

oncologyeducation.com site map

Site Search

Sign-up for Our E-Newsletter

Help Us Grow!

Networking

Information

Conferences

Residents

In The Clinic

COMET